Under the metabolic environment of type 2 diabetes mellitus (T2DM), activated platelets can release chemokines such as CXCL4, CXCL5, and CCL5 on vascular cell surfaces, triggering atherogenesis [42,43,44,45]. This evidence concerns the gene CXCL5 and type 2 diabetes mellitus.